Antibodies are the hosts, produced by the body within itself when any foreign entity enters the human body. The custom antibody works well in both qualitative and quantitative immune detection methods. Custom antibodies can be used in the treatment of particular infections or diseases. Customized antibodies can be generated in hamsters, rats, or mice to meet the requirements of hosts. There is a wide range of customized antibodies available in the market like a polyclonal recombinant antibody, hybridoma antibody, recombinant monoclonal antibody, polyclonal & monoclonal antibody, and others.
The significant surge in the research activities, particularly in the area of the life sciences sector along with increasing industry and academic collaborations is one of the major factors driving the growth of the global custom antibody services market. The growing initiatives from the government to lower the increasing burden of infectious diseases all across the globe are vigorously boosting the demand for custom antibodies. Also, there is a significant surge in demand for therapeutics of antibodies in order to expand the drug pipeline. Governments are undergoing partnership deals with private firms to fulfill the growing demand for custom antibodies. Moreover, the growing funding to strengthen the biotechnology sector are also likely to fuel the growth of the market in the forthcoming years.
The global custom antibody services market can be segmented into end-user, research area, source, service, and region.
By end-user, the market can be segmented into contract research organization, academic & research institute of a pharmaceutical, biotechnology company and others.
By research area, the market can be segmented into cardiovascular diseases, neurobiology, infectious diseases, stem cells, immunology, oncology, and others.
By source, the market can be segmented into rabbits, mice, and others.
By type, the market can be segmented into polyclonal antibodies, monoclonal antibodies, and others.
By service, the market can be segmented into antibody fragmentation & labeling, antibody production & purification, antibody development, and others.
North America accounts for the largest share in the global custom antibody services market due to the growing investments for the innovation and development of structure-based drug design along with significant growth in research activities in the field of proteomics and genomics.
Some of the significant players in the global custom antibody services market are Agilent Technologies, Cell Signaling Technology, Inc, ProMab, Rockland Immunochemicals, Inc, GenScript, ABCAM, Merck KGaA, BioLegend, Inc, Bio-Rad Laboratories Inc, and Thermo Fisher Scientific Inc. To cite, Giotto Biotech in March 2021 came up with specialized monoclonal and polyclonal production services. The company produces more than 500 monoclonal antibody types for therapeutic and diagnostic applications.